Open AccessAnticardiolipin Antibodies Are Not an Independent Risk Factor for Stroke
Author(s) -
Ejaz Ahmed,
Birgitta Stegmayr,
Jasmina Trifunovic,
Lars Weinehall,
Göran Hallmans,
Ann Kari Lefvert
Publication year - 2000
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.31.6.1289
Subject(s) - medicine , stroke (engine) , risk factor , diabetes mellitus , population , smokeless tobacco , physical therapy , surgery , endocrinology , tobacco use , mechanical engineering , environmental health , engineering
Anticardiolipin antibodies (aCL) have been proposed to be an independent risk factor for stroke. To test this hypothesis, a nested case-control study was performed to compare aCL with the other known risk factors for stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom